Glukoza B. Braun

Glukoza B. Braun is an injectable solution that contains glucose monohydrate as the active ingredient. It is supplied as a sterile parenteral carbohydrate solution for intravenous use. The product is marketed in the European Union and is classified as a prescription‑only excipient/solvent used in parenteral nutrition and fluid replacement. It provides a readily available source of carbohydrate for patients who require intravenous glucose supplementation.

Glukoza B. Braun is indicated for several clinical situations where intravenous carbohydrate support is needed.

- Treatment of hypoglycemia when oral glucose administration is not feasible. - Component of parenteral nutrition regimens to supply energy. - Fluid and electrolyte replacement in patients unable to tolerate oral intake. - Support during peri‑operative fasting to maintain blood glucose levels. - Adjunct therapy in critical care settings for metabolic stability.

Adverse reactions to Glukoza B. Braun are generally related to its osmolarity and glucose content.

Common: - Hyperglycemia or elevated blood glucose levels. - Local irritation at the infusion site. - Mild electrolyte disturbances, such as low potassium. - Transient nausea or vomiting.

Serious: - Severe hyperglycemia leading to diabetic ketoacidosis. - Fluid overload or pulmonary edema in susceptible patients. - Allergic reactions, including rash or anaphylaxis. - Hyperosmolar hyperglycemic state in patients with impaired glucose tolerance.

When prescribing Glukoza B. Braun, clinicians should consider patient‑specific factors and monitor relevant parameters.

- Assess baseline blood glucose and adjust infusion rate accordingly. - Monitor electrolytes, especially potassium and sodium, during therapy. - Use caution in patients with renal or cardiac insufficiency due to risk of fluid overload. - Avoid rapid infusion in neonates and infants to prevent hyperglycemia. - Discontinue or modify therapy if signs of allergic reaction develop. - Ensure proper aseptic technique to prevent catheter‑related infections.

Glukoza B. Braun may interact with other agents that affect glucose metabolism or fluid balance.

Avoid: - Concurrent use of high‑dose insulin without close glucose monitoring. - Co‑administration with other hypertonic glucose solutions, which may exacerbate hyperglycemia.

Use with caution: - Diuretics that may alter electrolyte status. - Beta‑blockers, which can mask symptoms of hypoglycemia. - Corticosteroids, as they can increase blood glucose levels. - Medications that cause fluid retention, such as ACE inhibitors. - Nutritional supplements containing carbohydrates.